Literature DB >> 33355208

DNA Polymerase and Mismatch Repair Exert Distinct Microsatellite Instability Signatures in Normal and Malignant Human Cells.

Jiil Chung1,2,3, Yosef E Maruvka4,5, Gad Getz6,5,7,8, Uri Tabori9,2,10, Sumedha Sudhaman1,2, Jacalyn Kelly1,2, Nicholas J Haradhvala4,5,11, Vanessa Bianchi1, Melissa Edwards1, Victoria J Forster1,2, Nuno M Nunes1,2, Melissa A Galati1,2,3, Martin Komosa1, Shriya Deshmukh12,13, Vanja Cabric14, Scott Davidson1,15, Matthew Zatzman1,16, Nicholas Light1,3,16, Reid Hayes1,15, Ledia Brunga1,15, Nathaniel D Anderson1,16, Ben Ho16, Karl P Hodel17, Robert Siddaway2, A Sorana Morrissy18,19, Daniel C Bowers20,21, Valérie Larouche22, Annika Bronsema23, Michael Osborn24, Kristina A Cole25,26, Enrico Opocher27, Gary Mason28, Gregory A Thomas29, Ben George30, David S Ziegler31,32, Scott Lindhorst33, Magimairajan Vanan34, Michal Yalon-Oren35, Alyssa T Reddy36, Maura Massimino37, Patrick Tomboc38, An Van Damme39, Alexander Lossos40, Carol Durno41,42, Melyssa Aronson41, Daniel A Morgenstern43, Eric Bouffet10, Annie Huang2,16,10, Michael D Taylor2,44, Anita Villani10, David Malkin10, Cynthia E Hawkins2,15,16,45, Zachary F Pursell17, Adam Shlien1,15,16, Thomas A Kunkel46.   

Abstract

Although replication repair deficiency, either by mismatch repair deficiency (MMRD) and/or loss of DNA polymerase proofreading, can cause hypermutation in cancer, microsatellite instability (MSI) is considered a hallmark of MMRD alone. By genome-wide analysis of tumors with germline and somatic deficiencies in replication repair, we reveal a novel association between loss of polymerase proofreading and MSI, especially when both components are lost. Analysis of indels in microsatellites (MS-indels) identified five distinct signatures (MS-sigs). MMRD MS-sigs are dominated by multibase losses, whereas mutant-polymerase MS-sigs contain primarily single-base gains. MS deletions in MMRD tumors depend on the original size of the MS and converge to a preferred length, providing mechanistic insight. Finally, we demonstrate that MS-sigs can be a powerful clinical tool for managing individuals with germline MMRD and replication repair-deficient cancers, as they can detect the replication repair deficiency in normal cells and predict their response to immunotherapy. SIGNIFICANCE: Exome- and genome-wide MSI analysis reveals novel signatures that are uniquely attributed to mismatch repair and DNA polymerase. This provides new mechanistic insight into MS maintenance and can be applied clinically for diagnosis of replication repair deficiency and immunotherapy response prediction.This article is highlighted in the In This Issue feature, p. 995. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33355208      PMCID: PMC8223607          DOI: 10.1158/2159-8290.CD-20-0790

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  65 in total

1.  Human mismatch repair: reconstitution of a nick-directed bidirectional reaction.

Authors:  Nicoleta Constantin; Leonid Dzantiev; Farid A Kadyrov; Paul Modrich
Journal:  J Biol Chem       Date:  2005-09-27       Impact factor: 5.157

2.  Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the constitutional mismatch repair deficiency consortium.

Authors:  Doua Bakry; Melyssa Aronson; Carol Durno; Hala Rimawi; Roula Farah; Qasim Kholaif Alharbi; Musa Alharbi; Ashraf Shamvil; Shay Ben-Shachar; Matthew Mistry; Shlomi Constantini; Rina Dvir; Ibrahim Qaddoumi; Steven Gallinger; Jordan Lerner-Ellis; Aaron Pollett; Derek Stephens; Steve Kelies; Elizabeth Chao; David Malkin; Eric Bouffet; Cynthia Hawkins; Uri Tabori
Journal:  Eur J Cancer       Date:  2014-01-15       Impact factor: 9.162

3.  Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes.

Authors:  S N Thibodeau; A J French; P C Roche; J M Cunningham; D J Tester; N M Lindor; G Moslein; S M Baker; R M Liskay; L J Burgart; R Honchel; K C Halling
Journal:  Cancer Res       Date:  1996-11-01       Impact factor: 12.701

4.  PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.

Authors:  Dung T Le; Jennifer N Uram; Hao Wang; Bjarne R Bartlett; Holly Kemberling; Aleksandra D Eyring; Andrew D Skora; Brandon S Luber; Nilofer S Azad; Dan Laheru; Barbara Biedrzycki; Ross C Donehower; Atif Zaheer; George A Fisher; Todd S Crocenzi; James J Lee; Steven M Duffy; Richard M Goldberg; Albert de la Chapelle; Minori Koshiji; Feriyl Bhaijee; Thomas Huebner; Ralph H Hruban; Laura D Wood; Nathan Cuka; Drew M Pardoll; Nickolas Papadopoulos; Kenneth W Kinzler; Shibin Zhou; Toby C Cornish; Janis M Taube; Robert A Anders; James R Eshleman; Bert Vogelstein; Luis A Diaz
Journal:  N Engl J Med       Date:  2015-05-30       Impact factor: 91.245

Review 5.  Clinical Management and Tumor Surveillance Recommendations of Inherited Mismatch Repair Deficiency in Childhood.

Authors:  Uri Tabori; Jordan R Hansford; Maria Isabel Achatz; Christian P Kratz; Sharon E Plon; Thierry Frebourg; Laurence Brugières
Journal:  Clin Cancer Res       Date:  2017-06-01       Impact factor: 12.531

6.  The 3'-->5' exonucleases of DNA polymerases delta and epsilon and the 5'-->3' exonuclease Exo1 have major roles in postreplication mutation avoidance in Saccharomyces cerevisiae.

Authors:  H T Tran; D A Gordenin; M A Resnick
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

Review 7.  Microsatellite instability and DNA mismatch repair deficiency testing in hereditary and sporadic gastrointestinal cancers.

Authors:  Adrian Gologan; Antonia R Sepulveda
Journal:  Clin Lab Med       Date:  2005-03       Impact factor: 1.935

8.  Mismatch repair-independent increase in spontaneous mutagenesis in yeast lacking non-essential subunits of DNA polymerase ε.

Authors:  Anna Aksenova; Kirill Volkov; Jaroslaw Maceluch; Zachary F Pursell; Igor B Rogozin; Thomas A Kunkel; Youri I Pavlov; Erik Johansson
Journal:  PLoS Genet       Date:  2010-11-18       Impact factor: 5.917

9.  The repertoire of mutational signatures in human cancer.

Authors:  Ludmil B Alexandrov; Jaegil Kim; Gad Getz; Steven G Rozen; Michael R Stratton; Nicholas J Haradhvala; Mi Ni Huang; Alvin Wei Tian Ng; Yang Wu; Arnoud Boot; Kyle R Covington; Dmitry A Gordenin; Erik N Bergstrom; S M Ashiqul Islam; Nuria Lopez-Bigas; Leszek J Klimczak; John R McPherson; Sandro Morganella; Radhakrishnan Sabarinathan; David A Wheeler; Ville Mustonen
Journal:  Nature       Date:  2020-02-05       Impact factor: 49.962

10.  Distinct mutational signatures characterize concurrent loss of polymerase proofreading and mismatch repair.

Authors:  N J Haradhvala; J Kim; Y E Maruvka; P Polak; D Rosebrock; D Livitz; J M Hess; I Leshchiner; A Kamburov; K W Mouw; M S Lawrence; G Getz
Journal:  Nat Commun       Date:  2018-05-01       Impact factor: 14.919

View more
  14 in total

1.  MetaMutationalSigs: Comparison of mutational signature refitting results made easy.

Authors:  Palash Pandey; Sanjeevani Arora; Gail L Rosen
Journal:  Bioinformatics       Date:  2022-02-14       Impact factor: 6.937

2.  Mouse model and human patient data reveal critical roles for Pten and p53 in suppressing POLE mutant tumor development.

Authors:  Vivian S Park; Meijuan J S Sun; Wesley D Frey; Leonard G Williams; Karl P Hodel; Juliet D Strauss; Sydney J Wellens; James G Jackson; Zachary F Pursell
Journal:  NAR Cancer       Date:  2022-03-03

3.  Mesothelioma Mouse Models with Mixed Genomic States of Chromosome and Microsatellite Instability.

Authors:  Yurong Song; Shaneen S Baxter; Lisheng Dai; Chelsea Sanders; Sandra Burkett; Ryan N Baugher; Stephanie D Mellott; Todd B Young; Heidi E Lawhorn; Simone Difilippantonio; Baktiar Karim; Yuwaraj Kadariya; Ligia A Pinto; Joseph R Testa; Robert H Shoemaker
Journal:  Cancers (Basel)       Date:  2022-06-24       Impact factor: 6.575

Review 4.  The Challenge of Diagnosing Constitutional Mismatch Repair Deficiency Syndrome in Brain Malignancies from Young Individuals.

Authors:  Cristina Carrato; Carolina Sanz; Ana María Muñoz-Mármol; Ignacio Blanco; Marta Pineda; Jesús Del Valle; Estela Dámaso; Manel Esteller; Eva Musulen
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

5.  Immune Checkpoint Inhibition as Primary Adjuvant Therapy for an IDH1-Mutant Anaplastic Astrocytoma in a Patient with CMMRD: A Case Report-Usage of Immune Checkpoint Inhibition in CMMRD.

Authors:  Rebekah Rittberg; Craig Harlos; Heidi Rothenmund; Anirban Das; Uri Tabori; Namita Sinha; Harminder Singh; Bernie Chodirker; Christina A Kim
Journal:  Curr Oncol       Date:  2021-02-01       Impact factor: 3.677

6.  Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency.

Authors:  Anirban Das; Sumedha Sudhaman; Daniel Morgenstern; Ailish Coblentz; Jiil Chung; Simone C Stone; Noor Alsafwani; Zhihui Amy Liu; Ola Abu Al Karsaneh; Shirin Soleimani; Hagay Ladany; David Chen; Matthew Zatzman; Vanja Cabric; Liana Nobre; Vanessa Bianchi; Melissa Edwards; Lauren C Sambira Nahum; Ayse B Ercan; Arash Nabbi; Shlomi Constantini; Rina Dvir; Michal Yalon-Oren; Gadi Abebe Campino; Shani Caspi; Valerie Larouche; Alyssa Reddy; Michael Osborn; Gary Mason; Scott Lindhorst; Annika Bronsema; Vanan Magimairajan; Enrico Opocher; Rebecca Loret De Mola; Magnus Sabel; Charlotta Frojd; David Sumerauer; David Samuel; Kristina Cole; Stefano Chiaravalli; Maura Massimino; Patrick Tomboc; David S Ziegler; Ben George; An Van Damme; Nobuko Hijiya; David Gass; Rose B McGee; Oz Mordechai; Daniel C Bowers; Theodore W Laetsch; Alexander Lossos; Deborah T Blumenthal; Tomasz Sarosiek; Lee Yi Yen; Jeffrey Knipstein; Anne Bendel; Lindsey M Hoffman; Sandra Luna-Fineman; Stefanie Zimmermann; Isabelle Scheers; Kim E Nichols; Michal Zapotocky; Jordan R Hansford; John M Maris; Peter Dirks; Michael D Taylor; Abhaya V Kulkarni; Manohar Shroff; Derek S Tsang; Anita Villani; Wei Xu; Melyssa Aronson; Carol Durno; Adam Shlien; David Malkin; Gad Getz; Yosef E Maruvka; Pamela S Ohashi; Cynthia Hawkins; Trevor J Pugh; Eric Bouffet; Uri Tabori
Journal:  Nat Med       Date:  2022-01-06       Impact factor: 87.241

Review 7.  Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers.

Authors:  Vito Amodio; Gianluca Mauri; Nicole M Reilly; Andrea Sartore-Bianchi; Salvatore Siena; Alberto Bardelli; Giovanni Germano
Journal:  Cancers (Basel)       Date:  2021-05-27       Impact factor: 6.639

Review 8.  Mutational signatures: emerging concepts, caveats and clinical applications.

Authors:  Gene Koh; Andrea Degasperi; Xueqing Zou; Sophie Momen; Serena Nik-Zainal
Journal:  Nat Rev Cancer       Date:  2021-07-27       Impact factor: 60.716

9.  Rare cases of medulloblastoma with hypermutation.

Authors:  Aditi Bagchi; Ian Beddows; Albert Cornelius; Giles W Robinson; Scott D Jewell
Journal:  Cancer Rep (Hoboken)       Date:  2021-08-05

Review 10.  Challenges of Neoantigen Targeting in Lynch Syndrome and Constitutional Mismatch Repair Deficiency Syndrome.

Authors:  Asima Abidi; Mark A J Gorris; Evan Brennan; Marjolijn C J Jongmans; Dilys D Weijers; Roland P Kuiper; Richarda M de Voer; Nicoline Hoogerbrugge; Gerty Schreibelt; I Jolanda M de Vries
Journal:  Cancers (Basel)       Date:  2021-05-13       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.